Diurnal Intraocular Pressure Self-monitoring (DIPS) in glaucoma patients on topical medication

Dr. Barbara Zangerl0 个研究点目标入组 19 人开始时间: 2018年6月19日最近更新: 2021年11月1日

适应症

试验速览

暂无简介。

•Group 1: Patients, diagnosed with glaucoma or ocular hypertension who are taking topical medications to reduce intraocular pressure (prostaglandin analogue or beta-blocker)
•Group 2: Patients, newly with diagnosed glaucoma or ocular hypertension who have been prescribed (but not yet started taking) a topical medication (prostaglandin analogue or beta-blocker) by the attending clinician.

•- Known sensitivity to latanoprost or timolol eye drops
•- History of breathing problems or pulmonary disease including asthma, chronic obstructive pulmonary disease
•- History of heart disease involving slowed heart rate, impaired electrical conduction of the heart (i.e. sinus bradycardia, AV block) or chronic heart failure.
•- Contact lens use
•- Only one functional eye, poor or eccentric fixation, nystagmus
•- Any corneal or conjunctival pathology or infection (keratoconus, corneal scarring, severe dry eye disease)
•- History of prior incisional glaucoma surgery or cornea surgery, including corneal laser surgery
•- Cataract extraction within the last two months in the study eye(s)
•- Sensory or functional impairments that may limit self-handling of the ICARE HOME tonometer
•- Lack of comprehension or willingness to use the tonometer as instructed

发起方

Dr. Barbara Zangerl